Aquatic Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Aquatic Capital Management's PFE Position: Q1 2026 in Review
Aquatic Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 711,196 shares — an estimated $17.7M sold.
Aquatic Capital Management first reported a position in PFE in Q1 2022 and held it in 5 quarters. The position peaked at $17.7M in Q4 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Aquatic Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Aquatic Capital Management sold 711,196 Pfizer shares in Q1 2026, an estimated $17.7M.
- Aquatic Capital Management first reported a position in Pfizer in Q1 2022 and held it in 5 quarters.
- Aquatic Capital Management's Pfizer position peaked at $17.7M in Q4 2025.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.